摘要
目的:观察益气活血中药对晚期非小细胞肺癌(NSCIC)患者介入化疗后免疫功能及生存期的影响。方法;54例Nsclc患者介入化疗后予益气活血中药(A组)与30例给予益气活血、散结祛瘀中药(B组)进行比较。结果:两组近期疗效相似,有效率为55.2%,58.3%(P>0.05),但1年生存期存在显著差异(P<0.05),各为85.1%,67.7%。免疫功能提高A组高于B组。结论:益气活血中药能更好地提高机体免疫力,延长中位生存期及远期生存率,CD+4及CD+4/CD+8数值变化可做为判断预后的一个重要指标。
Objective: To observe the effect of chinese medicinal herbs of strengthening vital energy -- activating blood(SVEAB)on the immunological function and survival time of non small cell lung cancer(Nsclc) patients, after they were treatedwith i n t erve nt ional-chemot he rapy. M ethods: By c o m P a r in g 5 4 p a t ten t s w it h N sc ic who were treared with SVE AB to 3 0 patientswith Nsclc who were treated with SVEAB and dispensing tumor after interventional- chemotherapy. Results: Effective rates were55. 2 in Group A, 58. 3% in Group B, There were no significant differences between Group A and B according to the short-timeresults(p>0. 05), But the survival time over one year were 85. 1 % in Group A, 67. 7% in B. There were significant differencesbetween Group A and B. The improving of immunological function in Group A is higher than that in Group B. Conclusion: Thechinese medicinal herbs of SVEAB can effectively improve immunological competence of body and lengthen the medial Survivaltime and The survival rate of long-time. The numerical changes of CD+4and CD+4 /CD+8 can be used as important indexes to judgethe prognosis.
出处
《现代中西医结合杂志》
CAS
1999年第7期1046-1047,共2页
Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词
肺癌
介入化疗
中药
免疫功能
生存期
lung cancer, Interventional- chemotherapy, Chinese Medicinal Herbs, Immunological- Function, Survival time.